Epidemiology of Hepatitis B Virus Hepatitis B virus (HBV) has infected more than 2 billion people worldwide, and approximately 350 million patients worldwide have chronic HBV infection. 1 , 2 In the United States, carriers of chronic
Search Results
Bhumsuk Keam, Jeong-Hoon Lee, Seock-Ah Im, and Jung-Hwan Yoon
Sarah P. Hammond, Sankar Swaminathan, William I. Bensinger, and Lindsey R. Baden
An estimated 2 billion people worldwide have been infected with hepatitis B virus (HBV). Of those, an estimated 240 million have chronic HBV infection. 1 , 2 In the United States, where HBV is nonendemic, an estimated 1.4 million people have
Caitlin A. Hester, Nicole E. Rich, Amit G. Singal, and Adam C. Yopp
the United States. 1 – 4 Typically occurring in a background of chronic liver disease and cirrhosis, the most common risk factors worldwide have traditionally included hepatitis B virus (HBV), hepatitis C virus (HCV), and alcohol-related liver disease
James J. Harding, Ghaith Abu-Zeinah, Joanne F. Chou, Dwight Hall Owen, Michele Ly, Maeve Aine Lowery, Marinela Capanu, Richard Do, Nancy E. Kemeny, Eileen M. O'Reilly, Leonard B. Saltz, and Ghassan K. Abou-Alfa
Board. Through retrospective chart review, we extracted demographic information (age, sex, race), HCC etiologic factors (eg, hepatitis B virus [HBV] infection, hepatitis C virus [HCV] infection, alcoholic liver disease, nonalcoholic steatohepatitis [NASH
Presenter: Stephen D. Smith
etiology of MZL, current treatment standards by subtype, and the role of targeted therapies ( Figure 1 ). Figure 1. Diagnosis of MZLs. Abbreviations: BM, bone marrow; CLL, chronic lymphocytic leukemia; HBV, hepatitis B virus; HCV, hepatitis C virus; FL
Matthias Holdhoff, Maciej M. Mrugala, Christian Grommes, Thomas J. Kaley, Lode J. Swinnen, Carlos Perez-Heydrich, and Lakshmi Nayak
-C, cytarabine; CSF, cerebrospinal fluid; HBV, hepatitis B virus; HCT/ASCT, high-dose chemotherapy and autologous stem cell transplant; HCV, hepatitis C virus; MTX, methotrexate; WBRT, whole-brain radiation therapy. Once the diagnosis is confirmed, treatment must
Kwang-Yu Chang, Jang-Yang Chang, and Yun Yen
. 23 Chalasani N Baluyut A Ismail A . Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study . Hepatology 2000 ; 31 : 7 – 11 . 24 Shepard CW Simard EP Finelli L . Hepatitis B virus
Sowmya Boddhula, Satish Kumar Boddhula, Bishesh Shrestha, Kelly Morris, and Rosana Gnanajothy
Introduction: Individuals with chronic hepatitis B virus infection (HBV) or previous infection with HBV are at increased risk of HBV exacerbation or reactivation when they receive treatment with anti-CD20 monoclonal antibodies like rituximab (RTX
En Cheng, Peiyin Hung, and Shi-Yi Wang
-Medicare database. Furthermore, the diagnosis of hepatitis B virus infection (HBV; ICD-9 codes 070.2, 070.3, V02.62), hepatitis C virus infection (HCV; ICD-9 codes 070.41, 070.44, 070.51, 070.54, 070.70, 070.71, V02.62), alcohol-related liver disease (ARLD; ICD-9
Andrew D. Zelenetz, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C. Byrd, Myron S. Czuczman, Luis E. Fayad, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nishitha Reddy, Lubomir Sokol, Lode Swinnen, Christina Tsien, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Mary A. Dwyer, and Maoko Naganuma
, particularly those receiving treatment that contains anti-CD20 monoclonal antibodies. Hepatitis B Virus Reactivation Hepatitis B virus (HBV) reactivation has been reported in patients treated with chemotherapy with or without immunotherapy agents. 32 - 38
